This is not the most recent version of the article. View current version (10 FEB 2014)

Intervention Review

Diacerein for osteoarthritis

  1. Tania S.A. Fidelix1,*,
  2. Bernardo Soares2,
  3. Virginia Fernandes Moça Trevisani3

Editorial Group: Cochrane Musculoskeletal Group

Published Online: 25 JAN 2006

Assessed as up-to-date: 15 NOV 2005

DOI: 10.1002/14651858.CD005117.pub2


How to Cite

Fidelix TS, Soares B, Fernandes Moça Trevisani V. Diacerein for osteoarthritis. Cochrane Database of Systematic Reviews 2006, Issue 1. Art. No.: CD005117. DOI: 10.1002/14651858.CD005117.pub2.

Author Information

  1. 1

    UNIFESP (ESCOLA PAULISTA DE MEDICINA), Internal Medicine and Therapeutic, São Bernardo, São Paulo, Brazil

  2. 2

    Brazilian Cochrane Centre, São Paulo, SP, Brazil

  3. 3

    UNISA (Santo Amaro University)/UNIFESP (Paulista Medicine School), Rheumatology/Internal Medicine and Therapeutics, Jardim Marajoara, Sao Paulo, Brazil

*Tania S.A. Fidelix, Internal Medicine and Therapeutic, UNIFESP (ESCOLA PAULISTA DE MEDICINA), Rua Mediterraneo 290 sl 13, São Bernardo, São Paulo, 09750 420, Brazil. tsafidelix@uol.com.br.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 25 JAN 2006

SEARCH

This is not the most recent version of the article. View current version (10 FEB 2014)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Kichul Shin, Joon Wan Kim, Ki won Moon, Ji Ae Yang, Eun Yeong Lee, Yeong Wook Song, Eun Bong Lee, The Efficacy of Diacerein in Hand Osteoarthritis: A Double-Blind, Randomized, Placebo-Controlled Study, Clinical Therapeutics, 2013, 35, 4, 431

    CrossRef

  2. 2
    Principles and Practice of Phytotherapy, 2013,

    CrossRef

  3. 3
    Kuljinder SINGH, Rakesh SHARMA, Jaswant RAI, Diacerein as adjuvant to diclofenac sodium in osteoarthritis knee, International Journal of Rheumatic Diseases, 2012, 15, 1
  4. 4
    W. Zhang, G. Nuki, R.W. Moskowitz, S. Abramson, R.D. Altman, N.K. Arden, S. Bierma-Zeinstra, K.D. Brandt, P. Croft, M. Doherty, M. Dougados, M. Hochberg, D.J. Hunter, K. Kwoh, L.S. Lohmander, P. Tugwell, OARSI recommendations for the management of hip and knee osteoarthritis, Osteoarthritis and Cartilage, 2010, 18, 4, 476

    CrossRef

  5. 5
    E.M. Bartels, H. Bliddal, P.K. Schøndorff, R.D. Altman, W. Zhang, R. Christensen, Symptomatic efficacy and safety of diacerein in the treatment of osteoarthritis: a meta-analysis of randomized placebo-controlled trials, Osteoarthritis and Cartilage, 2010, 18, 3, 289

    CrossRef

  6. 6
    Motoo Kikuchi, Kentaro Matsuura, Yoshifuji Matsumoto, Toshiaki Inagaki, Ryuzo Ueda, Bibliographical investigation of complementary alternative medicines for osteoarthritis and rheumatoid arthritis, Geriatrics & Gerontology International, 2009, 9, 1
  7. 7
    R.M. Rozendaal, E.J. Uitterlinden, G.J.V.M. van Osch, E.H. Garling, S.P. Willemsen, A.Z. Ginai, J.A.N. Verhaar, H. Weinans, B.W. Koes, S.M.A. Bierma-Zeinstra, Effect of glucosamine sulphate on joint space narrowing, pain and function in patients with hip osteoarthritis; subgroup analyses of a randomized controlled trial, Osteoarthritis and Cartilage, 2009, 17, 4, 427

    CrossRef

  8. 8
    George Liberopoulos, Nikolaos A. Trikalinos, John P.A. Ioannidis, The elderly were under-represented in osteoarthritis clinical trials, Journal of Clinical Epidemiology, 2009, 62, 11, 1218

    CrossRef

  9. 9
    S. Giménez Basallote, A. Gimeno Marqués, P. Panero Hidalgo, J.L. Casals Sánchez, De la evidencia a la práctica clínica: manejo de la artrosis, II parte, SEMERGEN - Medicina de Familia, 2008, 34, 4, 193

    CrossRef

  10. 10
    Gabriel Sanfélix-Gimeno, Begoña Reig-Mollá, José Sanfélix-Genovés, Vicente Giner-Ruiz, Efectividad de los fármacos utilizados como modificadores de la enfermedad artrósica, Medicina Clínica, 2008, 130, 12, 463

    CrossRef

  11. 11
    W. Zhang, R.W. Moskowitz, G. Nuki, S. Abramson, R.D. Altman, N. Arden, S. Bierma-Zeinstra, K.D. Brandt, P. Croft, M. Doherty, M. Dougados, M. Hochberg, D.J. Hunter, K. Kwoh, L.S. Lohmander, P. Tugwell, OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines, Osteoarthritis and Cartilage, 2008, 16, 2, 137

    CrossRef

  12. 12
    S. Giménez Basallote, Tratamiento de la artrosis en Atención Primaria: revisión de los fármacos de acción sintomática lenta (SYSADOA), SEMERGEN - Medicina de Familia, 2008, 34, 8, 400

    CrossRef

  13. 13
    W. Zhang, R.W. Moskowitz, G. Nuki, S. Abramson, R.D. Altman, N. Arden, S. Bierma-Zeinstra, K.D. Brandt, P. Croft, M. Doherty, M. Dougados, M. Hochberg, D.J. Hunter, K. Kwoh, L.S. Lohmander, P. Tugwell, OARSI recommendations for the management of hip and knee osteoarthritis, Part I: Critical appraisal of existing treatment guidelines and systematic review of current research evidence, Osteoarthritis and Cartilage, 2007, 15, 9, 981

    CrossRef

  14. 14
    Gabriel Sanfélix-Gimeno, Begoña Reig-Mollá, José Sanfélix-Genovés, Vicente Giner-Ruiz, Revisión de la evidencia sobre los fármacos sintomáticos de acción lenta en la artrosis (SYSADOA), Medicina Clínica, 2007, 129, 16, 624

    CrossRef

  15. 15
    Shasha Li, Bo Yu, Dong Zhou, Chengqi He, Qi Zhuo, Jennifer M Hulme, Electromagnetic fields for treating osteoarthritis, The Cochrane Library,